Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Anthera Pharma Prices $40 Mln Stock Offering

RELATED NEWS
Trade ANTH now with 

Anthera Pharmaceuticals, Inc. (ANTH: Quote) said Friday that it has priced an underwritten public offering of about 60.6 million shares of its common stock, offered at a price of $0.66 per share.

The company estimates that the gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Anthera, will be $40.0 million.

In addition, the company has granted the underwriters a 30-day option to purchase up to an additional about 9.1 million shares of common stock.

The offering is expected to close on or about January 30.

The company plans to use the net proceeds from the offering for general corporate purposes.

Click here to receive FREE breaking news email alerts for Anthera Pharmaceuticals, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Fashion retailer Gap Inc. said Thursday after the markets closed that its second quarter profit rose 10% from last year, helped by higher sales and a gain from asset sale. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarter sales. Separately, Gap announced plans to enter India through franchise-operated Gap brand stores in 2015. While buying interest was somewhat subdued, stocks moved mostly higher over the course of the trading day on Thursday. The gains on the day extended the recent upward trend by the markets, lifting the S&P 500 to a new record closing high. Republicans have not found much to like about President Barack Obama's nearly six years in office, but the results of a new Washington Post-ABC News poll show that a vast majority support the president's decision to launch airstrikes in Iraq.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.